FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration
- PMID: 11365123
Item in Clipboard
FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration
AIDS Treat News.
.
Abstract
AIDS: The Food and Drug Administration (FDA) published new rules defining conflict of interests between drug companies and medical researchers and clinicians. Certain financial arrangements will need to be disclosed, although the FDA estimates that only one to ten percent of pharmaceutical companies will need to submit disclosures for one or more of their investigators. The purpose of the new rule is to prevent bias in safety and efficacy studies of drugs and medical devices. The full rule is published in the Federal Register.
Similar articles
-
Financial disclosure by clinical investigators--FDA. Final rule.Fed Regist. 1998 Feb 2;63(21):5233-54. Fed Regist. 1998. PMID: 10177332
-
Intellectual property issues in a clinical trial: a corporate perspective.Qual Assur. 1992 Jun;1(3):237-48. Qual Assur. 1992. PMID: 1344679 No abstract available.
-
Financial disclosure by clinical investigators; correction--FDA. Final rule; correction.Fed Regist. 1998 Jun 29;63(124):35134. Fed Regist. 1998. PMID: 10180634
-
The impact of escalating regulatory requirements on the conduct of clinical research.Cytotherapy. 2003;5(4):309-13. doi: 10.1080/14653240310002225. Cytotherapy. 2003. PMID: 12944237 Review.
-
The draft FDA guideline on non-inferiority clinical trials: a critical review from European pharmaceutical industry statisticians.Pharm Stat. 2011 Sep-Oct;10(5):414-9. doi: 10.1002/pst.508. Epub 2011 Sep 19. Pharm Stat. 2011. PMID: 21932294 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical